Would I FIE to You? FDA’s First Interchangeable Exclusivity Determination Results in Expiration
FDA Law Blog
JANUARY 11, 2024
In other words, FDA needed to determine whether the initial biosimilar litigation—pre-interchangeable supplemental approval—counts towards the FIE expiration date calculation. Notably, the purpose of the statute seemed to govern much of FDA’s interpretation.
Let's personalize your content